Emessar Biotech to review quarterly results at a Mumbai board meeting on August 7 Back
Emessar Biotech & Nutrition Limited will hold a board meeting on August 7, 2026, in Mumbai to consider and approve unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing with the Bombay Stock Exchange. The trading window for equity shares of the company will remain closed until August 9, 2026, in accordance with SEBI regulations.